210 related articles for article (PubMed ID: 9178028)
1. Repeated administration of growth hormone-releasing hormone with or without previous administration of pyridostigmine in insulin-dependent diabetes mellitus.
Martina V; Bruno G; Tagliabue M; Maccario M; Bertaina S; Zumpano E; Arvat E; Ghigo E; Camanni F
Horm Metab Res; 1997 Apr; 29(4):180-3. PubMed ID: 9178028
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback.
Ismail IS; Scanlon MF; Peters JR
Clin Endocrinol (Oxf); 1993 Feb; 38(2):149-57. PubMed ID: 8094648
[TBL] [Abstract][Full Text] [Related]
3. Differences in reproducibility and peak growth hormone responses to repeated testing with various stimulators in healthy adults.
Hoeck HC; Jakobsen PE; Vestergaard P; Falhof J; Laurberg P
Growth Horm IGF Res; 1999 Feb; 9(1):18-24. PubMed ID: 10207504
[TBL] [Abstract][Full Text] [Related]
4. Blunted GH response to growth hormone-releasing hormone (GHRH) alone or combined with arginine in non-insulin-dependent diabetes mellitus.
Martina V; Bruno G; Tagliabue M; Bertaina S; Maccario M; Grottoli S; Procopio M; Ozzello A; Camanni F
Horm Metab Res; 1995 Jan; 27(1):26-30. PubMed ID: 7729789
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children.
Guzzaloni G; Grugni G; Morabito F
Minerva Endocrinol; 1998 Dec; 23(4):99-104. PubMed ID: 10361807
[TBL] [Abstract][Full Text] [Related]
6. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
Procopio M; Maccario M; Savio P; Valetto MR; Aimaretti G; Grottoli S; Oleandri SE; Baffoni C; Tassone F; Arvat E; Camanni F; Ghigo E
Panminerva Med; 1998 Mar; 40(1):13-7. PubMed ID: 9573747
[TBL] [Abstract][Full Text] [Related]
7. Effect of growth hormone releasing hormone on growth hormone, prostaglandin E2 and insulin in non-insulin-dependent diabetic patients.
Koev D; Zacharieva S; Popova J; Andonova K
Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):137-40. PubMed ID: 8740245
[TBL] [Abstract][Full Text] [Related]
8. An inhibition of the hypothalamic somatostatinergic tone is not the cause of the enhanced growth hormone response to growth hormone-releasing hormone in patients with liver cirrhosis.
Fanciulli G; Tomasi PA; Giusti M; Bertoncelli A; Deplano A; Garrucciu G; Delitala G
Exp Clin Endocrinol Diabetes; 2008 Mar; 116(3):148-51. PubMed ID: 18095239
[TBL] [Abstract][Full Text] [Related]
9. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
Cordido F; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
[TBL] [Abstract][Full Text] [Related]
10. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome.
Procopio M; Invitti C; Maccario M; Grottoli S; Cavagnini F; Camanni F; Ghigo E
Int J Obes Relat Metab Disord; 1995 Feb; 19(2):108-12. PubMed ID: 7735336
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by salbutamol of GHRH-induced GH release in type 1 diabetes mellitus.
Martina V; Miola C; Maccario M; Talliano M; Arvat E; Ghigo E; Camanni F
Horm Metab Res; 1992 Nov; 24(11):520-3. PubMed ID: 1333441
[TBL] [Abstract][Full Text] [Related]
12. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin?
Peñalva A; Burguera B; Casabiell X; Tresguerres JA; Dieguez C; Casanueva FF
Neuroendocrinology; 1989 May; 49(5):551-4. PubMed ID: 2566942
[TBL] [Abstract][Full Text] [Related]
13. Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man.
Arvat E; Di Vito L; Ramunni J; Gianotti L; Giordano R; Deghenghi R; Camanni F; Ghigo E
Clin Endocrinol (Oxf); 1997 Oct; 47(4):495-500. PubMed ID: 9404449
[TBL] [Abstract][Full Text] [Related]
14. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man.
Peñalva A; Carballo A; Pombo M; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1993 Jan; 76(1):168-71. PubMed ID: 8421084
[TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity.
Maccario M; Tassone F; Gianotti L; Lanfranco F; Grottoli S; Arvat E; Muller EE; Ghigo E
J Clin Endocrinol Metab; 2001 Jan; 86(1):167-71. PubMed ID: 11231996
[TBL] [Abstract][Full Text] [Related]
16. Pyridostigmine potentiates growth hormone (GH)-releasing hormone-induced GH release in both men and women.
Arvat E; Cappa M; Casanueva FF; Dieguez C; Ghigo E; Nicolosi M; Valcavi R; Zini M
J Clin Endocrinol Metab; 1993 Feb; 76(2):374-7. PubMed ID: 8432781
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone (GH) response to GH-releasing peptide-6 in patients with insulin-dependent diabetes mellitus.
Villas-Boas Weffort RF; Ramos-Dias JC; Chipoch C; Lengyel AM
Metabolism; 1997 Jun; 46(6):706-10. PubMed ID: 9186309
[TBL] [Abstract][Full Text] [Related]
18. Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man.
Giustina A; Girelli A; Doga M; Bodini C; Bossoni S; Romanelli G; Wehrenberg WB
J Clin Endocrinol Metab; 1990 Sep; 71(3):580-4. PubMed ID: 2118535
[TBL] [Abstract][Full Text] [Related]
19. Pyridostigmine partially restores the GH responsiveness to GHRH in normal aging.
Ghigo E; Goffi S; Arvat E; Nicolosi M; Procopio M; Bellone J; Imperiale E; Mazza E; Baracchi G; Camanni F
Acta Endocrinol (Copenh); 1990 Aug; 123(2):169-73. PubMed ID: 2220258
[TBL] [Abstract][Full Text] [Related]
20. Comparison of growth hormone-releasing effect of growth hormone-releasing hormone, clonidine and pyridostigmine in normal children and adolescents. GH-releasing effect of GHRH, clonidine and pyridostigmine.
Ghigo E; Arvat E; Nicolosi M; Mazza E; Camanni F
Panminerva Med; 1990; 32(1):1-3. PubMed ID: 2263395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
